|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,480 JPY | +1.02% |
|
-5.76% | -12.19% |
| Apr. 17 | Japan Inc makes a renewed U.S. push as China fears mount | RE |
| Apr. 15 | Middle East Tensions Blunt Asian Stock Markets Excepting China | MT |
May 12 (Reuters) - The U.S. Food and Drug Administration on Friday approved a non-hormonal therapy from Japanese drugmaker Astellas Pharma Inc for treatment of symptoms associated with menopause. (Reporting by Raghav Mahobe in Bengaluru; Editing by Shounak Dasgupta)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,626 PTS | -1.91% | -4.39% | - | ||
| 1,480 JPY | +1.02% | -5.76% | 17B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -12.19% | 17B | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
ASTELLAS PHARMA INC. 
